2015 American Transplant Congress

Sunday, May 3, 2015

5:30pm-6:30pm

Immunomodulatory Strategies Directed Towards Tolerance of Vascularized Composite Allografts

M. Madariaga, K. Shanmugarajah, S. Michel, V. Villani, G. La Muraglia II, R. Torabi, D. Leonard, M. Randolph, R. Colvin, K. Yamada, J. Madsen, C. Cetrulo, Jr., D. Sachs.

Poster Session B: Vascularized Composite Tissue Allografts and Xenotransplantation  •  Exhibit Hall E

5:30pm-6:30pm

Impact of Donor Age on Longterm Outcomes in Asian Kidney Transplant Recipients: A Multicenter Cohort Study

K. Yoo,¹ J. An,² J.-H. Cho,³ C.-D. Kim,³ S.-K. Park,⁴ D.-W. Chae,⁵ Y. Oh,² C. Lim,² Y. Kim,¹ Y. Kim,⁶ J. Lee.²

Poster Session B: Obesity/Elderly/Frail  •  Exhibit Hall E

5:30pm-6:30pm

Impact of Machine Perfusion After Long Static Cold Storage On Delayed Graft Function Incidence and Duration and Time to Hospital Discharge

A. Matos,¹ M. Borrelli, Jr.,¹ L. Moura Requiao,¹ M. Nogueira, Jr.,¹ L. Pertusier,¹ G. Clarizia,¹ P. Ongaro,¹ S. Ximenes,¹ M. Durao, Jr.,^1,2 A. Pacheco-Silva.^1,2

Poster Session B: Kidney and Donor Evaluation/Utilization  •  Exhibit Hall E

5:30pm-6:30pm

Impacts of Mycophenolate Mofetile Addition to Very Low Exposure Everolimus and Calcineurine Inhibitor Based Immunosuppression in De Novo Kidney Transplantation

Y. Watarai,¹ M. Okada,¹ K. Futamura,¹ K. Ito,¹ T. Yamamoto,¹ M. Tsujita,¹ T. Hiramitsu,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²

Poster Session B: Clinical Science: Kidney Immunosuppression: Novel Agents  •  Exhibit Hall E

5:30pm-6:30pm

Improved Bioavailability and Reduced Dose Requirements of Novel, Once-Daily, MeltDose® Tacrolimus Formulation Tablets (Envarsus® XR) Compared to Twice-Daily Tacrolimus Capsules (Prograf®) in De Novo Kidney Transplantation: Results of a Phase 3 Double-Dummy, Randomized Trial

J. Grinyó,¹ S. Bunnapradist,² S. Mulgaonkar,³ S. Steinberg.⁴

Poster Session B: Clinical Science: Kidney Immunosuppression: Novel Agents  •  Exhibit Hall E

5:30pm-6:30pm

Improving Latent Tuberculosis Diagnosis Before Kidney Transplantation in a Developing Country

G. Meinerz,^1,2 C. da Silva,^1,2 E. Keitel,^1,2 A. Pasqualotto,³ J. Goldani,^1,2 C. Zeni,^1,4 F. Vacilotto,^1,4 N. Prado,^1,4 A. Monteiro,^2,3 D. Seelig,¹ F. Klaus,¹ J. Andrade,¹ V. Garcia.¹

Poster Session B: Bacterial/Fungal/Other Infections  •  Exhibit Hall E

5:30pm-6:30pm

Improving the Predictive Value of the Virtual Crossmatch: Is the C1Q Assay Needed?

A. Colovai,¹ C. Savchik,¹ P. Masiakos,¹ S. Calp-Inal,² L. Kayler,³ E. Akalin.²

Poster Session B: Translational Genetics and Proteomics in Transplantation  •  Exhibit Hall E

5:30pm-6:30pm

In Pre-Implantation Biopsies Expression of Micro RNAs Is Not a Good Surrogate for Established mRNA Markers of Kidney Injury

K. Famulski,¹ S. Niederhaus,² J. Reeve,¹ J. Bromberg,² P. Halloran.¹

Poster Session B: Kidney and Donor Evaluation/Utilization  •  Exhibit Hall E

5:30pm-6:30pm

Incidence and Risk Factors of Contrast-Induced Nephropathy in Renal Allograft Recipients

B. Abu Jawdeh, Y. Sharma, S. Katipally, A. Leonard, R. Alloway, E. Woodle, C. Thakar.

Poster Session B: Radiology/Renal Artery Stenosis  •  Exhibit Hall E

5:30pm-6:30pm

Incidence and Risks Associated With Clostridium Difficile Infection in the Pediatric Solid Organ Transplantation Population: A Single-Center Retrospective Review

L. Danziger-Isakov,¹ J. Ciricillo,² S. Blum,¹ M.-O. Kim,¹ C. Liu,¹ G. Paulsen,¹ J. Courter,¹ D. Haslam.¹

Poster Session B: Bacterial/Fungal/Other Infections  •  Exhibit Hall E